RXST Q2 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$35M+67.6% YoY

Gross Profit

$24M69.5% margin

Operating Income

-$8M-23.9% margin

Net Income

-$6M-17.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+18.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$6M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$305M

Total Liabilities

$30M

Stockholders' Equity

$275M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$21M	+67.6%
Gross Profit	$24M	$12M	+101.8%
Operating Income	-$8M	-$14M	+38.8%
Net Income	-$6M	-$14M	+56.0%

Revenue Segments

L D D

$10M92%

Service Warranty Service Contracts And Accessories

$870,0008%